GlassScriptPhysician profile
Ronald G Ebb
NPI 1851333546
$7,087.79
in general payments reported to CMS, 2019-2025
50 companies · $1,921 in 2025
The $1,921 reported for 2025 was more than what 79% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $433 · 2020: $375 · 2021: $1,163 · 2022: $894 · 2023: $1,273 · 2024: $1,028 · 2025: $1,921.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,117 · Education: $105.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,117.41 |
| Education | $104.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $798.12 | 2019-2025 | Xtandi |
| Janssen Biotech, INC. | $797.81 | 2021-2025 | Erleada, Akeega |
| Sumitomo Pharma America, INC. | $339.98 | 2023-2025 | Gemtesa, Orgovyx |
| Urogen Pharma, INC. | $321.52 | 2020-2021 | |
| Teleflex LLC | $289.58 | 2021-2025 | Urolift, Barrigel |
| Procept Biorobotics Corporation | $288.41 | 2024-2025 | Aquabeam System |
| Bayer Healthcare Pharmaceuticals INC. | $284.19 | 2022-2025 | |
| Antares Pharma, INC. | $242.71 | 2020-2025 | Xyosted, Nocdurna, Tlando |
| Axonics, INC. | $240.13 | 2021-2023 | Axonics |
| Ferring Pharmaceuticals INC. | $231.00 | 2019-2025 | Adstiladrin |
| Astrazeneca Pharmaceuticals LP | $223.16 | 2020-2024 | Lynparza |
| Endo Pharmaceuticals INC. | $220.28 | 2019-2023 | Xiaflex, Aveed |
| Myriad Genetic Laboratories, INC. | $214.06 | 2020-2025 | Prolaris, Myrisk |
| Merck Sharp & Dohme LLC | $198.94 | 2021-2025 | Keytruda, Welireg, Lynparza |
| Laborie Medical Technologies Corp. | $198.75 | 2023-2025 | Optilume Bph Drug Coated Balloon Catheter |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $194.90 | 2019-2025 | Lupron Depot, Botox |
| Pfizer INC. | $163.91 | 2019-2024 | |
| Acerus Pharmaceuticals Corporation | $149.47 | 2020-2022 | |
| Histosonics, INC. | $148.89 | 2025 | |
| Boston Scientific Corporation | $111.77 | 2022-2024 | Rezum Generator, Tria Firm, Spaceoar Vue System - 10ml |
| Endo USA, INC. | $95.55 | 2024-2025 | Aveed, Xiaflex |
| Tolmar, INC. | $88.26 | 2023-2025 | Jatenzo, Eligard |
| Immunitybio, INC. | $86.57 | 2025 | |
| Medtronic USA, INC. | $83.05 | 2019 | |
| Halozyme INC | $78.64 | 2023 | |
| Neotract INC. | $73.57 | 2019-2020 | |
| Coloplast Corp | $71.02 | 2022-2025 | |
| Bluewind Medical | $65.47 | 2025 | |
| C. R. Bard, INC. & Subsidiaries | $65.10 | 2020-2024 | Bard Urinary Drainage Bag |
| Urovant Sciences INC | $65.03 | 2021-2022 | |
| Dendreon Pharmaceuticals LLC | $62.74 | 2025 | Provenge |
| Telix Pharmaceuticals | $55.16 | 2024-2025 | Illuccix |
| Progenics Pharmaceuticals, INC. | $54.75 | 2021-2025 | Pylarify |
| Blue Earth Diagnostics | $50.73 | 2019-2022 | |
| Myovant Sciences INC. | $44.65 | 2021-2022 | |
| 180 Medical, INC. | $42.52 | 2025 | Gentlecath |
| Accord Healthcare, INC. | $41.91 | 2022-2025 | |
| Rochester Medical Corporation | $39.98 | 2021-2022 | |
| Valencia Technologies Corporation | $36.61 | 2025 | Ecoin Device Kit |
| Davol INC. | $32.45 | 2025 | Magic3 Go Intermittent Urinary Catheter |
| Ethicon INC. | $30.57 | 2021 | |
| Calyxo, INC. | $26.21 | 2025 | Cvac Aspiration System |
| Foundation Medicine, INC. | $20.25 | 2022 | |
| Convatec INC. | $19.97 | 2025 | |
| Novartis Pharmaceuticals Corporation | $18.73 | 2024 | |
| Abc Home Medical Supply, INC. | $18.53 | 2025 | |
| Allergan, INC. | $18.18 | 2019 | |
| Olympus America INC. | $16.64 | 2025 | Itind System |
| Medtronic, INC. | $16.48 | 2023 | Interstim |
| Tolmar Pharmaceuticals, INC. | $10.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Ebb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.